When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XBIT - XBiotech up 4% premarket on positive bermekimab data
XBiotech Inc.
XBiotech (NASDAQ:XBIT) is up 4% premarket, albeit on only 600 shares, on the heels of positive results from a Phase 2 clinical trial evaluating bermekimab in patients with a chronic inflammatory skin disorder called hidradenitis suppurativa (HS), first reported in late January. The data were presented at the American Academy of Dermatology Annual Meeting in Washington, DC.
More news on: Xbiotech, Healthcare stocks news, Stocks on the move,